December 18, 2020 First-quarter catalysts for the smaller players Important data releases are on the cards for Rhythm, Wave and Supernus, among others.
October 21, 2020 Amylyx provides hope in amyotrophic lateral sclerosis Amylyx believes it has found a disease-modifying therapy in AMX0035, as other key readouts approach.
July 24, 2019 Biogen leads the way in renewed amyotrophic lateral sclerosis push The company has quietly emerged as the key player to watch in an area that has seen several setbacks of late.